BME
BlackRock Health Sciences Trust
1W: -3.4%
1M: -4.8%
3M: +0.1%
YTD: +6.5%
1Y: +16.3%
3Y: +29.6%
5Y: +18.4%
$43.34
-0.27 (-0.62%)
Weekly Expected Move ±1.8%
$42
$43
$43
$44
$45
ETF-Level Metrics
AUM$560M
Holdings130
Top 10 Wt48.7%
Beta0.59
% Profitable33%
Coverage91%
Portfolio Valuation
P/E26.4
P/B6.6
P/S3.5
EV/EBITDA19.8
P/FCF27.8
PEG1.43
Profitability & Returns
Gross Margin61.2%
Net Margin12.7%
ROE25.6%
ROA9.0%
ROIC19.1%
Div Yield1.29%
Leverage & Liquidity
Debt/Equity0.85
Debt/Assets0.30
Net Debt/EBITDA1.3x
Interest Cov15.5x
Current Ratio1.28
Quick Ratio0.98
Growth (YoY)
Revenue+21.6%
Net Income+9.2%
EPS+11.6%
FCF+35.7%
EBITDA+31.5%
Rev CAGR 3Y+21.9%
Quality Scores
Piotroski F5.7
Altman Z18.06
IS Quality69.5
IS Overall59.3
IS Value41.4
Median P/E-2.0
Sector Breakdown
6 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 125 | 92.7% | -7.8 |
| Other | 29 | 5.8% | — |
| Energy | 1 | 0.7% | -1.1 |
| Industrials | 1 | 0.6% | 6.6 |
| Technology | 1 | 0.3% | 44.0 |
| Financial Services | 2 | 0.3% | -0.0 |
Smart Money Overlap
0 holdings with signalsNo holdings with active convergence signals
Showing 50 of 159 holdings
· Page 1 of 4
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & Johnson | JNJ.SW | 10.75% | $57.3M | 234,293 | 29.6 | $535.1B | Healthcare |
| 2 | Eli Lilly & Co | LLY.SW | 10.26% | $54.6M | 59,379 | 38.2 | $851.6B | Healthcare |
| 3 | Merck & Co Inc | 6MK.DE | 5.36% | $28.6M | 237,354 | 114.5 | $314.9B | Healthcare |
| 4 | AbbVie Inc | 4AB.DE | 4.11% | $21.9M | 100,720 | 74.0 | $408.1B | Healthcare |
| 5 | Gilead Sciences Inc | GILD.SW | 3.94% | $21.0M | 150,487 | -55.7 | $143.2B | Healthcare |
| 6 | Amgen Inc | 4332.HK | 3.43% | $18.2M | 51,861 | — | $998.5B | Healthcare |
| 7 | UnitedHealth Group Inc | UNH.DE | 3.04% | $16.2M | 59,867 | 23.9 | $295.9B | Healthcare |
| 8 | BlackRock Liquidity Funds Private | — | 2.89% | $15.4M | 15,410,175 | — | — | — |
| 9 | Pfizer Inc | PFE.DE | 2.75% | $14.7M | 522,250 | 36.7 | $140.3B | Healthcare |
| 10 | Vertex Pharmaceuticals Inc | VX1.DE | 2.68% | $14.3M | 31,983 | 29.1 | $113.3B | Healthcare |
| 11 | Intuitive Surgical Inc | 0R29.L | 2.38% | $12.7M | 27,505 | 44.3 | $140.2B | Healthcare |
| 12 | Abbott Laboratories | ABT.SW | 2.30% | $12.3M | 119,561 | 31.4 | $125.5B | Healthcare |
| 13 | Edwards Lifesciences Corp | EW | 2.25% | $12.0M | 149,905 | 48.9 | $49.0B | Healthcare |
| 14 | Danaher Corp | DAP.DE | 1.94% | $10.3M | 54,385 | 37.9 | $134.5B | Healthcare |
| 15 | Thermo Fisher Scientific Inc | TN8.DE | 1.76% | $9.4M | 19,123 | 35.2 | $214.6B | Healthcare |
| 16 | Teva Pharmaceutical Industries Ltd Private | — | 1.72% | $9.2M | 304,107 | — | — | — |
| 17 | Boston Scientific Corp | BSX.F | 1.57% | $8.3M | 132,943 | 17.2 | $55.9B | Healthcare |
| 18 | Stryker Corp | 0R2S.L | 1.46% | $7.8M | 23,649 | 28.3 | $103.0B | Healthcare |
| 19 | Argenx SE | ARGNF | 1.46% | $7.8M | 10,637 | 33.3 | $58.2B | Healthcare |
| 20 | Medtronic PLC | 2M6.DE | 1.25% | $6.7M | 77,050 | 21.1 | $98.6B | Healthcare |
| 21 | AstraZeneca PLC | ZEG.DE | 1.24% | $5.0M | 33,842 | 23.4 | $249.2B | Healthcare |
| 22 | Regeneron Pharmaceuticals Inc | 0R2M.L | 1.12% | $6.0M | 7,712 | 17.6 | $79.6B | Healthcare |
| 23 | Biogen Inc | BIIB.SW | 1.10% | $5.8M | 31,869 | 30.0 | $20.8B | Healthcare |
| 24 | Bristol-Myers Squibb Co | BMY.SW | 1.10% | $5.8M | 96,259 | 13.5 | $87.7B | Healthcare |
| 25 | Insmed Inc | 0JAV.L | 1.06% | $5.7M | 34,614 | -27.0 | $23.7B | Healthcare |
| 26 | HCA Healthcare Inc | 0J1R.L | 0.97% | $5.2M | 10,937 | 14.2 | $96.2B | Healthcare |
| 27 | Cencora Inc | ABC | 0.94% | $5.0M | 15,981 | 13.3 | $36.1B | Healthcare |
| 28 | Rhythm Pharmaceuticals Inc | RYTM | 0.76% | $4.1M | 46,799 | -29.8 | $6.4B | Healthcare |
| 29 | Penumbra Inc | PENMF | 0.72% | $3.8M | 11,606 | -1.1 | $125M | Energy |
| 30 | IDEXX Laboratories Inc | 0J8P.L | 0.71% | $3.8M | 6,712 | 36.4 | $40.9B | Healthcare |
| 31 | Guardant Health Inc | GH | 0.69% | $3.7M | 39,876 | -50.9 | $23.9B | Healthcare |
| 32 | Dexcom Inc | DXCM | 0.68% | $3.6M | 57,910 | 33.0 | $32.2B | Healthcare |
| 33 | Protagonist Therapeutics Inc | PTGX | 0.63% | $3.4M | 32,058 | 115.0 | $9.0B | Healthcare |
| 34 | Novartis AG | NVS.JO | 0.63% | $3.3M | 21,810 | 6.6 | $1.8B | Industrials |
| 35 | Galderma Group AG | GALD.SW | 0.61% | $2.6M | 16,599 | 47.4 | $37.4B | Healthcare |
| 36 | Waters Corp | 0LTI.L | 0.61% | $3.3M | 10,927 | 105.8 | $31.8B | Healthcare |
| 37 | Incyte Corp | 0J9P.L | 0.61% | $3.3M | 34,568 | 14.2 | $22.8B | Healthcare |
| 38 | Medline Inc | MDLN | 0.59% | $3.1M | 70,645 | 41.4 | $30.1B | Healthcare |
| 39 | Nuvalent Inc | NUVL | 0.55% | $2.9M | 28,618 | -20.5 | $9.1B | Healthcare |
| 40 | United Therapeutics Corp | UTHR | 0.55% | $2.9M | 4,903 | 17.9 | $23.0B | Healthcare |
| 41 | Cogent Biosciences Inc | COGT | 0.52% | $2.8M | 72,020 | -13.4 | $5.3B | Healthcare |
| 42 | Alnylam Pharmaceuticals Inc | 0HD2.L | 0.52% | $2.8M | 8,378 | 36.0 | $29.7B | Healthcare |
| 43 | Agilent Technologies Inc | 0HAV.L | 0.51% | $2.7M | 23,884 | 33.0 | $53.3B | Healthcare |
| 44 | McKesson Corp | 0JZU.L | 0.49% | $2.6M | 2,993 | 24.0 | $110.2B | Healthcare |
| 45 | Revolution Medicines Inc | RVMD | 0.49% | $2.6M | 26,560 | -23.3 | $43.9B | Healthcare |
| 46 | Moderna Inc | 0QF.F | 0.47% | $2.5M | 48,852 | -23.8 | $66.4B | Healthcare |
| 47 | Natera Inc | NTRA | 0.44% | $2.4M | 11,821 | -301.7 | $58.8B | Healthcare |
| 48 | CVS Health Corp | CVS.DE | 0.43% | $2.3M | 31,771 | 22.6 | $98.2B | Healthcare |
| 49 | Elevance Health Inc | ANTM | 0.42% | $2.3M | 7,713 | 2.1 | $114.6B | Healthcare |
| 50 | IQVIA Holdings Inc | 0JDM.L | 0.40% | $2.1M | 12,502 | 31.8 | $43.5B | Healthcare |